HE Chuan, MA Di, GONG Ping, et al. Allicin Inhibits Epithelial-mesenchymal Transition of Human Pancreatic Cancer PANC-1 Cells[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(14): 130-134.
HE Chuan, MA Di, GONG Ping, et al. Allicin Inhibits Epithelial-mesenchymal Transition of Human Pancreatic Cancer PANC-1 Cells[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(14): 130-134. DOI: 10.13422/j.cnki.syfjx.2016140130.
Objective: To investigate the effect of allicin on epithelial-mesenchymal transition (EMT) of pancreatic cancer cells. Method: The PANC-1 cells were cultured and treated with 10 μg · L-1 transforming growth factor-β1 (TGF-β1)
10 μg · L-1 TGF-β1+5 μg · L-1 allicin
5 μg · L-1 allicin
respectively. Untreated cells were used for the normal control. Morphological changes were observed under inverted microscope. Wound scratch assay were performed to further identify if allicin could reduce the migration ability of PANC-1 cells. The expressions of E-cadherin and Vimentin in pancreatic cancer cells were detected by immunocytochemistry and Western blot. Result: The TGF-β1 can make PANC-1 cells show typical EMT morphological changes
which were accompanied by up-regulation of E-cadherin expression and down-regulation of Vimentin. Wound scratch assay indicated that allicin could reduce the migration ability of PANC-1 cells. According to the results of immunocytochemistry and Western blot
compared with the control group and the TGF-β1 group
the protein expression of E-cadherin was up-regulated in the allicin group (P<0.05)
and that of aimentin was down-regulated (P<0.05). Conclusion: Allicin can inhibit the EMT of human pancreatic cancer PANC-1 cells
and may play an important role in the inhibition of tumor invasion and metastasis.